Breadcrumb Home Carlos Slim Center for Health Research News 2021 Tackling diabetes from every angle 2020 Dozens of non-oncology drugs can kill cancer cells How a lung injury study helped inspire new COVID-19 drug trials New genetic vulnerability found in upwards of a third of all cancers 2019 Loss of a DNA repair system creates a unique vulnerability in many cancer types Massive sequencing study links rare DNA alterations to type 2 diabetes A molecular traffic jam may underlie a rare kidney disease and several other protein misfolding disorders 2018 Upgraded computational tool boosts search for cancer vulnerabilities 2017 The breast cancer genome’s “dark matter” starts to give up some secrets Turning risk-association to biological insight in T2D After a decade of genome-wide association studies, a new phase of discovery pushes on 2014 International team unearths strong genetic risk factor for type 2 diabetes in Latin American populations 2013 International team completes systematic, genomic study of cervical cancer New genetic risk factor for type 2 diabetes revealed Mexico-US genomics partnership launches second phase Bringing out the usual – and unusual – cancer genomics suspects Kidney disease mutations found in a genomic blind spot 2012 Two-way exchange Breast cancer’s many drivers 2011 Convergence in head and neck cancer 2010 Mexico-US collaboration launched SIGMA Scientific Areas Cancer Diabetes Kidney Disease Building Scientific Capacity News Events Partner Institutions En Español El Centro Carlos Slim para la Investigación en Salud Latest news News 04.29.2025 Sentinel program among finalists for the $100 Million 100&Change competition News 04.16.2025 WhyIScience Q&A: How a chemist moved to the business side of science News 04.09.2025 Potential Alzheimer’s disease therapeutic target identified in brain immune cells News 04.05.2025 David Liu receives Breakthrough Prize in Life Sciences All news